Multivitamins Capable of Reversing Cognitive Decline

There is evidence that multivitamin supplements can slow the onset of cognitive decline. One study showed that multivitamins reduced the rate of cognitive decline in older people by 60%. The supplementation also improved memory and executive function. The benefits lasted for two years. Interestingly, the multivitamins did not have any effect on cocoa intake, which is linked to increased cognitive decline.

Moreover, the individual B vitamins have important clinical and disease-modifying effects. For example, folic acid supplementation was found to reduce levels of homocysteine and slow the process of cognitive decline. In addition, the effects of vitamin B vitamins on homocysteine levels were also seen.

Low vitamin D concentrations are also linked with cognitive impairment and dementia. For example, low vitamin D concentrations are associated with executive dysfunction (impaired mental shifting and processing speed). There is also a modest association between low vitamin D levels and episodic memory. There are several systematic reviews that suggest that vitamin D levels are associated with cognitive decline and Alzheimer’s disease.

A recent study found that phosphatidylserine, an important phospholipid in the brain, can reverse cognitive decline in elderly people. Supplementation of this phospholipid improved memory and emotional health in the elderly. It is important to note that the study only tested a small number of patients, but it provides a strong indication that multivitamins can reverse the onset of cognitive decline.

The ReCODE program is a multifactor therapeutic program that aims to target genetic and biochemical risk factors associated with the development of Alzheimer’s disease. This program involves seven core strategies, including optimizing brain function, addressing metabolic dysfunction, and targeted supplementation.

The association between low vitamin D levels and dementia has been established in animal studies. However, the causal relationship remains unclear. Interventional studies on vitamin D supplementation have shown mixed results. The sample size of existing RCTs is small, and there is no consensus on the optimal age for initiation of vitamin D supplements. Large double-blinded, randomized trials are needed to find definitive results.

Related Articles

Back to top button